Dolhofer R, Renner R, Wieland O H
Diabetologia. 1981 Sep;21(3):211-5. doi: 10.1007/BF00252656.
Glycosylated haemoglobin (HbA1a-c) and serum albumin (glycosyl-albumin) have been determined in patients with severe diabetic ketoacidosis and non-acidotic coma. Within one week of therapy the level of glycosyl-albumin decreased from 184 mmol 5-hydroxymethylfurfural (HMF)/mol albumin to 152 mmol HMF/mol albumin (p less than 0.01) and was gradually lowered by some 40% during a period of 17 days. In contrast, the level of HbA1a-c remained unchanged. From these observations and findings in a patient with insulinoma, it appears that glycosyl-albumin provides a more acute measure of variation in relative glycaemia than HbA1a-c, and may prove useful as a measure of medium-term diabetes control.
已对重症糖尿病酮症酸中毒和非酸中毒昏迷患者测定了糖化血红蛋白(HbA1a - c)和血清白蛋白(糖基化白蛋白)。在治疗的一周内,糖基化白蛋白水平从184 mmol 5 - 羟甲基糠醛(HMF)/mol白蛋白降至152 mmol HMF/mol白蛋白(p < 0.01),并在17天内逐渐降低约40%。相比之下,HbA1a - c水平保持不变。基于这些观察结果以及在一名胰岛素瘤患者中的发现,似乎糖基化白蛋白比HbA1a - c能更敏锐地反映相对血糖水平的变化,并且可能被证明是一种衡量中期糖尿病控制情况的有用指标。